🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of this study is to compare a Dual Antithrombotic Therap...
Status
Completed
Location
Cardiology P.C.
Start Date
2014-07-22
Trial ID
NCT02164864
To validate the dosing algorithm for dabigatran etexilate in patients recei...
Status
Terminated
Location
1160.113.32003 Boehringer Ingelheim Investigational Site
Start Date
2011-10
Trial ID
NCT01452347
The purpose of this study is to evaluate the efficacy and safety of new ora...
Status
Unknown
Location
Anhui Provincial Hospital
Start Date
2020-05-08
Trial ID
NCT04066764
Treatments Being Tested
A prospective, comparative study evaluating warfarin initiation in a dose o...
Status
Completed
Location
The Cardiovascular Hospital
Start Date
2018-03-01
Trial ID
NCT04235569
Treatments Being Tested
The purpose of this dose-ranging pilot study is to compare Recombinant Acti...
Status
Terminated
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00770718
Treatments Being Tested
One of the well-known of complications post colonic polypectomy is bleeding...
Status
Unknown
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02375646
Treatments Being Tested
Interethnic differences in warfarin dose requirements in the Asian populati...
Status
Unknown
Location
University of Malaya Medical Centre
Start Date
2006-08
Trial ID
NCT00700895
Treatments Being Tested
The drug-drug interaction study had been designed to investigate the effect...
Status
Active Not Recruiting
Location
Dongguan People's Hospital
Start Date
2025-04-14
Trial ID
NCT07362030
Treatments Being Tested
The EINSTEIN program showed that oral rivaroxaban is effective and safe tre...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2013-11
Trial ID
NCT01986192
Treatments Being Tested
To collect additional data relating to safety and indicators of efficacy fo...
Status
Terminated
Location
1160.138.32003 Boehringer Ingelheim Investigational Site
Start Date
2011-12
Trial ID
NCT01505881